Clinical aspects of ACE inhibition in patients with acute myocardial infarction

Cardiovascular Drugs and Therapy
Claudio Borghi, E Ambrosioni

Abstract

The purpose of the present article was to review the current evidence on the use of angiotensin-converting enzyme (ACE) inhibitors in acute myocardial infarction (MI). This article is based on published information as well as on our personal experience derived from an extensive analysis of the SMILE study. All the randomized trials have been included irrespective of the primary endpoint, and the results are presented in terms of either hemodynamic or clinical benefit. Short- and long-term treatment with ACE inhibitors in patients with acute MI results in a significant reduction in mortality, which is more evident in high risk patients (i.e., patients with left ventricular dysfunction, congestive heart failure on admission, or anterior myocardial infarction). Development and progression of congestive heart failure after myocardial infarction was significantly reduced by ACE inhibition, which also reduced the rate of reinfarction, the need for revascularization procedures, as well as the occurrence of ventricular arrhythmias, probably through a mechanism involving some drug-dependent effects. In conclusion, the available data strongly support a wide benefit associated with the use of ACE inhibitors in patients with high-risk acut...Continue Reading

References

Nov 1, 1991·Circulation Research·L B TanK T Weber
Jul 14, 1988·The New England Journal of Medicine·M A PfefferE Braunwald
Aug 1, 1988·British Heart Journal·H M McAlpineH J Dargie
Jul 1, 1994·Journal of the American College of Cardiology·R A WrightK A Fox
Mar 1, 1993·British Heart Journal·S G RayS M Cobbe
Mar 1, 1997·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·O BazzinoR Méndez

❮ Previous
Next ❯

Citations

Oct 24, 1998·Journal of Clinical Pharmacy and Therapeutics·J C DoyleH Stubbs
Nov 4, 2006·Expert Review of Cardiovascular Therapy·Hendrik Buikema
Apr 2, 2005·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Pieter J de KamWiek H van Gilst
Sep 15, 1998·Journal of Cardiovascular Pharmacology·C Borghi, E Ambrosioni
May 13, 1998·Circulation·N J Brown, D E Vaughan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.